Literature DB >> 18385071

NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis.

Holly L Rosenzweig1, Tammy M Martin, Monica M Jann, Stephen R Planck, Michael P Davey, Koichi Kobayashi, Richard A Flavell, James T Rosenbaum.   

Abstract

PURPOSE: NOD2 plays an important role in the recognition of intracellular bacteria through its ability to sense the components of bacterial peptidoglycan (PGN), namely muramyl dipeptide (MDP) and muramyl tripeptide (MTP). Specific mutations in the human NOD2 gene cause Blau syndrome, an autosomal dominant form of uveitis, arthritis, and dermatitis. As a first step toward understanding the role of NOD2 in the pathogenesis of uveitis, the authors developed a mouse model of MDP-dependent uveitis.
METHODS: BALB/c mice and mice deficient in L-selectin or NOD2 received intravitreal injection of MDP, MTP, or PGN. The intravascular response within the iris and cellular infiltration was quantified by intravital microscopy and histologic assessment.
RESULTS: MDP induced an acute, ocular inflammatory response, wherein rolling and adhering leukocytes within the vasculature were significantly increased within 6 hours after MDP treatment. A minor increase in cellular infiltration occurred at 12 hours after MDP treatment. The adhesion molecule L-selectin participated in MDP-induced vascular inflammation because L-selectin knockout mice showed a significant decrease in the number of rolling cells. Importantly, NOD2 plays an essential role in ocular inflammation induced by MDP, as indicated by the fact that uveitis did not develop in Nod2 knockout mice in response to MDP. Nod2 knockout mice also showed abolished ocular inflammation in response to MTP but not to PGN treatment.
CONCLUSIONS: These findings demonstrate a novel mouse model of uveitis, wherein NOD2 plays an essential role in inflammation induced by the minimal components of PGN. Thus, innate immune responses mediated by NOD2 may participate in the development of uveitis in response to bacterial products.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385071      PMCID: PMC2430189          DOI: 10.1167/iovs.07-1174

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.

Authors:  Y Ogura; N Inohara; A Benito; F F Chen; S Yamaoka; G Nunez
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

Review 2.  Nods: a family of cytosolic proteins that regulate the host response to pathogens.

Authors:  Naohiro Inohara; Yasunori Ogura; Gabriel Nuñez
Journal:  Curr Opin Microbiol       Date:  2002-02       Impact factor: 7.934

Review 3.  NOD-LRR proteins: role in host-microbial interactions and inflammatory disease.

Authors:  Christine McDonald; Gabriel Nuñez
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

4.  CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.

Authors:  S E Girardin; R Tournebize; M Mavris; A L Page; X Li; G R Stark; J Bertin; P S DiStefano; M Yaniv; P J Sansonetti; D J Philpott
Journal:  EMBO Rep       Date:  2001-07-19       Impact factor: 8.807

5.  Human Nod1 confers responsiveness to bacterial lipopolysaccharides.

Authors:  N Inohara; Y Ogura; F F Chen; A Muto; G Nuñez
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

6.  CARD15 mutations in Blau syndrome.

Authors:  C Miceli-Richard; S Lesage; M Rybojad; A M Prieur; S Manouvrier-Hanu; R Häfner; M Chamaillard; H Zouali; G Thomas; J P Hugot
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

7.  Reduced leukocyte migration, but normal rolling and arrest, in interleukin-8 receptor homologue knockout mice.

Authors:  M D Becker; L M O'Rourke; W S Blackman; S R Planck; J T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

8.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  Synergy between TLR2 and TLR4: a safety mechanism.

Authors:  E Beutler; T Gelbart; C West
Journal:  Blood Cells Mol Dis       Date:  2001 Jul-Aug       Impact factor: 3.039

View more
  23 in total

1.  Investigation of the differential potentials of TLR agonists to elicit uveitis in mice.

Authors:  Jordan J Allensworth; Stephen R Planck; James T Rosenbaum; Holly L Rosenzweig
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

2.  Impact of IL-1 signalling on experimental uveitis and arthritis.

Authors:  Stephen R Planck; April Woods; Jenna S Clowers; Martin J Nicklin; James T Rosenbaum; Holly L Rosenzweig
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

3.  Contrasting ocular effects of local versus systemic endotoxin.

Authors:  James T Rosenbaum; April Woods; Jelena Kezic; Stephen R Planck; Holly L Rosenzweig
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-17       Impact factor: 4.799

Review 4.  NLRs in immune privileged sites.

Authors:  Holly L Rosenzweig; Stephen R Planck; James T Rosenbaum
Journal:  Curr Opin Pharmacol       Date:  2011-07-29       Impact factor: 5.547

5.  Interferon-γ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis.

Authors:  Jelena M Kezic; Michael P Davey; Tibor T Glant; James T Rosenbaum; Holly L Rosenzweig
Journal:  Arthritis Rheum       Date:  2012-03

6.  Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis.

Authors:  Ellen J Lee; Jordan J Allensworth; Jenna S Clowers; Holly L Rosenzweig
Journal:  Clin Exp Ophthalmol       Date:  2014-10-30       Impact factor: 4.207

7.  Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF.

Authors:  J Kezic; S Taylor; S Gupta; S R Planck; H L Rosenzweig; J T Rosenbaum
Journal:  J Leukoc Biol       Date:  2011-05-24       Impact factor: 4.962

8.  Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus.

Authors:  Travis Kochan; Anuj Singla; Joaquin Tosi; Ashok Kumar
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

9.  NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.

Authors:  Holly L Rosenzweig; Kellen T Galster; Stephen R Planck; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

Review 10.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.